Skip to content

Visualising blood vessel disease in the eye in COVID-19

Visualising vasculopathy in COVID-19 using portable fundoscopy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN59449699
Enrollment
30
Registered
2020-08-07
Start date
2020-09-28
Completion date
Unknown
Last updated
2020-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 (SARS-CoV-2 infection) Infections and Infestations COVID-19 (SARS-CoV-2 infection)

Interventions

1. Perform bedside fundal photography with or without optical coherence tomography on patients with COVID-19 at baseline and 4 week follow up 2. Assess tolerability of bedside fundal p

Sponsors

North Bristol NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 28/09/2020: 1. Emergency Department or hospital admission for symptoms related to COVID-19 2. Aged =18 years or over, there is no upper age limit Previous inclusion criteria: 1. Emergency Department or hospital admission for symptoms related to COVID-19 2. Aged =18 years 3. Fluency in English

Exclusion criteria

Exclusion criteria: 1. COVID-19 patients receiving palliative care 2. Eye disease precluding fundoscopy 3. Significant agitation precluding safe practice of fundoscopy

Design outcomes

Primary

MeasureTime frame
1. Safety of performing the study measured using adverse events reported throughout the study 2. Tolerability of the study measured using a modified version of participant and clinician self-report intervention acceptability questionnaire at a single time

Secondary

MeasureTime frame
1. Retinal vascular abnormalities will be quantified using proxy-Early Treatment Diabetic Retinopathy Study (ETDRS)/International Clinical Grading system grading of retinopathy and maculopathy and artificial intelligence software (e.g. EyeArt™) using fundal photography at baseline and 4 weeks 2. Macular and peripapillary retinal thickness and the thickness of the retinal layers will be analysed according to standard retinopathy parameters using optical coherence tomography data at baseline and 4 weeks (where available)

Countries

United Kingdom

Contacts

Public ContactClaire Rice
c.m.rice@bristol.ac.uk+44 (0)1174146695

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026